Orthobiologics Market Analysis With Key Players, Applications, Trends and Forecasts 2023-2033

Published July 31, 2023

New York, United States, Mon, 31 Jul 2023 06:42:20 / Comserve Inc. / -- Research Nester published a report titled “Orthobiologics Market: Global Demand Analysis & Opportunity Outlook 2033”

Research Nester published a report titled Orthobiologics Market: Global Demand Analysis & Opportunity Outlook 2033” which delivers a detailed overview of the global orthobiologics market in terms of market segmentation by solution, application, end-user, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, and supply and demand risk, along with a detailed discussion of current and future market trends that are associated with the growth of the market.

The global orthobiologics market is projected to grow at a CAGR of ~6% by attaining robust revenue during the forecast period, i.e., 2023 – 2033. Increment in the sales of orthopedic devices is anticipated to propel the growth of the market during the forecast period. In 2022, the orthopedic device segment was estimated to hit around USD 40 billion. Additionally, rising cases of orthopedic injuries are further estimated to propel the market growth over the forecast period. For instance, it observed that about 6 million orthopedic surgeries are performed annually.

Additionally, by end-user, the global orthobiologics market is segmented into clinics and hospitals. Out of these sub-segments, the hospitals segment is estimated to obtain the largest share in the market during the forecast period. The growth of the segment can be accounted to a significant escalation in the number of people visiting hospitals. As of 2019, nearly 7% of the USA population was estimated to be hospitalized.

Request Free Sample Copy of this Report@ https://www.researchnester.com/sample-request-773

Furthermore, the global orthobiologics market, by region, is bifurcated into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. Out of these regions, the market in the North America region is estimated to grow at a significant pace over the forecast period on the back of the growing geriatric population in the region with significant bone diseases. As of 2021, the World Bank published a report showing that the geriatric population of the USA was started to reach 56,545,938. 

The research is global in nature and covers a detailed analysis of the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of the Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook, etc. have also been covered and displayed in the research report.

Spiking Number of Bone Fractures to Foster the Growth of the Market

The annual rate of fracture received by per 100,000 people is estimated to be around 1000.

Orthobiologics is a therapy that is utilized to treat fractured bone by using various components in a short period. These components are bone grafting materials, scaffolds to reinforce tissue and cell therapies. Bones become quite fragile as a person grows old and it takes a long time to fix them if they are injured in some ways. Therefore, such a requirement is anticipated to propel the growth of the market during the forecast period.

However, the lack of skilled medical professionals and requisite technology is expected to operate as a key restraint to the growth of the global orthobiologics market over the forecast period.

Make an Inquiry Before Buying this Report@ https://www.researchnester.com/inquiries-before-buying-773

This report also provides the existing competitive scenario of some of the key players in the global orthobiologics market which include company profiling of Medtronic plc, Wright Medical Group N.V., Zimmer Biomet Holdings, Inc., Arthrex, Inc., Medical Device Business Services, Inc., Johnson & Johnson & Services, Inc., RTI Surgical, Inc., MTG Learning Media Pvt. Ltd., Bioventus LLC, and Stryker Corporation. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials, and recent news and developments. On the whole, the report depicts a detailed overview of the global orthobiologics market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching for possibilities, and other stakeholders to align their market-centric strategies according to the ongoing and expected trends in the future.

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

For more information, please contact:

AJ Daniel

Research Nester
Email: [email protected]
Tel: +1 646 586 9123

The post Orthobiologics Market Analysis With Key Players, Applications, Trends and Forecasts 2023-2033 appeared first on Comserveonline.

Comserve Online